You just read:

Nuvo Pharmaceuticals™ Inc. Announces Pennsaid 2% Phase 3 Trial to Support Regulatory Approvals in the E.U., Canada and Australia

News provided by

Nuvo Pharmaceuticals Inc.

13 Jul, 2016, 07:30 ET